Managed Healthcare Executive: CAR-T cell therapy moves beyond hospitals, raising new questions for payers | AMCP Annual 2026 - Prime Therapeutics

In the News

Managed Healthcare Executive: CAR-T cell therapy moves beyond hospitals, raising new questions for payers | AMCP Annual 2026

Managed Healthcare Executive: As CAR-T therapy expands into earlier stages of treatment and new care settings, payers are weighing access, cost savings and utilization management strategies

by Briana Contreras

April 15, 2026

About Prime Therapeutics

Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization. We offer innovative pharmacy benefit management, specialty and medical drug management, and state government solutions to millions of people across the country. At Prime, we’re reimagining pharmacy solutions to provide the care we’d want for our loved ones. We challenge the way it’s always been done to develop intelligently designed solutions that deliver savings, simplicity and support to help people achieve better health. For more information, visit us at PrimeTherapeutics.com or follow us on LinkedIn.

In the News

AJMC: Oncology Innovation Outpaces Managed Care’s Ability to Keep Up

April 15, 2026

In the News

Managed Healthcare Executive: Gene therapy brims with promise. The reality has been less rosy for some therapies | AMCP Annual 2026

April 15, 2026

In the News

Managed Healthcare Executive: CAR-T cell therapy moves beyond hospitals, raising new questions for payers | AMCP Annual 2026

April 15, 2026

In the News

Managed Healthcare Executive: Data and workflows have to be aligned for integrated pharmacy benefits | AMCP Annual 2026

April 14, 2026

Showing 1 to 4 of 141

Research & Publications

Oncology Insights - April 2026

April 16, 2026

Research & Publications

Research abstract: Real-World 3-Year Cost Impact Assessment of Glucagon-Like Peptide-1 Agonists to Treat Obesity Among Commercially Insured Members Without Diabetes

April 13, 2026

Research & Publications

Research abstract: Obesity Care Management Program 6-Month Outcomes and Glucagon-Like Peptide-1 (GLP-1) Therapy Persistence Among Commercially Insured Adults Without Diabetes

April 13, 2026

Research & Publications

10 research posters presented at AMCP 2026

April 13, 2026

Showing 1 to 4 of 215

Latest News

Oncology Insights - April 2026

Learn more

Managing blood disorders should be simple. Here’s how Prime helps.

Prime Therapeutics offers holistic and data-driven solutions to manage drug costs and simplify the patient experience for those with hemophilia and other blood disorders

Learn more

How integrated medical and pharmacy benefits improves specialty drug management

Prime Therapeutics experts share how rising costs are leading to innovation in benefit management

Learn more

Navigating the complex cell and gene therapy market

Prime Therapeutics experts share insights about the classification, cost and impact of these revolutionary drugs

Learn more

About us

Corporate social responsibility

Solutions overview

Modern technology

Drug access

Clinical solutions

Condition management

Specialty drug management

Government solutions

Single-state programs

Read

Watch

Listen

Home Delivery

Specialty Pharmacy